Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Northrop Grumman
NOC
|
+$305M |
| 2 |
Prologis
PLD
|
+$97.9M |
| 3 |
Carlisle Companies
CSL
|
+$29.2M |
| 4 |
Healthcare Realty
HR
|
+$28.7M |
| 5 |
Gaming and Leisure Properties
GLPI
|
+$27.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$102M |
| 2 |
DRE
Duke Realty Corp.
DRE
|
+$91.2M |
| 3 |
Chevron
CVX
|
+$54.7M |
| 4 |
CTXS
Citrix Systems Inc
CTXS
|
+$52.9M |
| 5 |
Microsoft
MSFT
|
+$27.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.12% |
| 2 | Healthcare | 15.83% |
| 3 | Consumer Discretionary | 12.65% |
| 4 | Industrials | 8.88% |
| 5 | Communication Services | 8.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1576
PRA Group
PRAA
$762M
| $3.1M | ﹤0.01% |
94,400
-8,700
| -8% | -$324K |
|
|
PDM
1577
Piedmont Realty Trust
PDM
$1.2B
| $3.09M | ﹤0.01% |
292,500
+2,200
| +0.8% | +$27.6K |
|
1578
Axsome Therapeutics
AXSM
$11.2B
| $3.09M | ﹤0.01% |
69,200
+2,600
| +4% | +$130K |
|
1579
Agilysys
AGYS
$3.25B
| $3.08M | ﹤0.01% |
55,700
+400
| +0.7% | +$20.2K |
|
1580
First Bancorp
FBNC
$2.74B
| $3.08M | ﹤0.01% |
84,200
| – | – |
|
1581
Triumph Financial Inc
TFIN
$1.87B
| $3.07M | ﹤0.01% |
56,500
| – | – |
|
1582
Enovix
ENVX
$966M
| $3.06M | ﹤0.01% |
190,743
+1,143
| +0.6% | +$16.9K |
|
1583
Hilltop Holdings
HTH
$2.28B
| $3.04M | ﹤0.01% |
122,500
+1,200
| +1% | +$32.7K |
|
1584
ADT
ADT
$5.46B
| $3.02M | ﹤0.01% |
403,900
+41,200
| +11% | +$311K |
|
1585
Kratos Defense & Security Solutions
KTOS
$11.8B
| $3.01M | ﹤0.01% |
296,400
+3,300
| +1% | +$44.2K |
|
1586
Century Communities
CCS
$2.04B
| $3.01M | ﹤0.01% |
70,266
-1,600
| -2% | -$77.5K |
|
1587
Shutterstock
SSTK
$217M
| $3M | ﹤0.01% |
59,900
| – | – |
|
1588
TTM Technologies
TTMI
$14.6B
| $3M | ﹤0.01% |
227,600
-6,900
| -3% | -$99.5K |
|
1589
AAR Corp
AIR
$5.77B
| $3M | ﹤0.01% |
83,600
| – | – |
|
1590
Opendoor
OPEN
$3.54B
| $3M | ﹤0.01% |
995,100
+8,887
| +0.9% | +$40.8K |
|
1591
Phreesia
PHR
$780M
| $2.99M | ﹤0.01% |
117,500
+2,800
| +2% | +$69.9K |
|
1592
Griffon
GFF
$4.8B
| $2.99M | ﹤0.01% |
101,400
+1,900
| +2% | +$57.7K |
|
1593
AdaptHealth
AHCO
$760M
| $2.99M | ﹤0.01% |
159,200
+5,000
| +3% | +$103K |
|
|
OPTU
1594
Optimum Communications Inc
OPTU
$228M
| $2.99M | ﹤0.01% |
512,800
+4,200
| +0.8% | +$40.2K |
|
|
MODV
1595
DELISTED
ModivCare
MODV
| $2.99M | ﹤0.01% |
30,000
+200
| +0.7% | +$20.7K |
|
|
CANO
1596
DELISTED
Cano Health, Inc.
CANO
| $2.99M | ﹤0.01% |
3,448
+49
| +1% | +$30.7K |
|
1597
Marten Transport
MRTN
$1.24B
| $2.98M | ﹤0.01% |
155,475
-1,000
| -0.6% | -$20K |
|
|
PGTI
1598
DELISTED
PGT, Inc.
PGTI
| $2.98M | ﹤0.01% |
142,100
+1,100
| +0.8% | +$22.6K |
|
|
CPRX
1599
DELISTED
Catalyst Pharmaceutical
CPRX
| $2.97M | ﹤0.01% |
231,700
| – | – |
|
|
DVAX
1600
DELISTED
Dynavax Technologies
DVAX
| $2.97M | ﹤0.01% |
284,578
+16,200
| +6% | +$211K |
|
Similar funds
Swiss National Bank's Q3 2022 Portfolio in Review
As of Q3 2022, Swiss National Bank held 2,744 positions worth $140B, down 5.4% from $148B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Trading was light in Q3 2022: portfolio turnover was 1.2%. Swiss National Bank opened 4 new positions and exited 30, leaving the 2,744-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 26% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Swiss National Bank's largest Q3 2022 buy was Northrop Grumman: 639,945 shares worth $301M.
- Swiss National Bank added most to Prologis in Q3 2022, an estimated $97.9M increase.
- Swiss National Bank's biggest Q3 2022 reduction was Apple, cutting an estimated $102M.
- Swiss National Bank fully exited Duke Realty Corp. in Q3 2022, selling an estimated $91.2M.
- Swiss National Bank's ten largest holdings make up 26% of its $140B portfolio in Q3 2022.
- Swiss National Bank opened 4 new positions and closed 30 in Q3 2022.
- Swiss National Bank's portfolio value fell 5.4% quarter-over-quarter to $140B.
Based on Swiss National Bank's 13F filing for Q3 2022, filed 9 Nov 2022.